0001628280-24-005380.txt : 20240216
0001628280-24-005380.hdr.sgml : 20240216
20240216170915
ACCESSION NUMBER: 0001628280-24-005380
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240213
FILED AS OF DATE: 20240216
DATE AS OF CHANGE: 20240216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Baldry Mark
CENTRAL INDEX KEY: 0001644137
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38295
FILM NUMBER: 24649421
MAIL ADDRESS:
STREET 1: C/O AMICUS THERAPEUTICS
STREET 2: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: X4 Pharmaceuticals, Inc
CENTRAL INDEX KEY: 0001501697
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 273181608
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 61 NORTH BEACON STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02134
BUSINESS PHONE: 857-529-8300
MAIL ADDRESS:
STREET 1: 61 NORTH BEACON STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02134
FORMER COMPANY:
FORMER CONFORMED NAME: Arsanis, Inc.
DATE OF NAME CHANGE: 20100920
4
1
wk-form4_1708121338.xml
FORM 4
X0508
4
2024-02-13
0
0001501697
X4 Pharmaceuticals, Inc
XFOR
0001644137
Baldry Mark
C/O X4 PHARMACEUTICALS, INC.
61 NORTH BEACON STREET 4TH FLOOR
BOSTON
MA
02134
0
1
0
0
Chief Commercial Officer
0
Stock Appreciation Right
0.921
2024-02-13
4
A
0
523414
0
A
2034-02-13
Common Stock
523414
523414
D
The Stock Appreciation Right will vest and become exercisable in equal annual installments (rounding down to the nearest whole share, except for the last installment) on the first, second, and third anniversaries of February 13, 2024, subject to the Reporting Person remaining an
employee of the Issuer through and including each applicable vesting date.
/s/ Adam S. Mostafa, attorney-in-fact
2024-02-16